Site records / Maharashtra / FEI 3004698222
Colgate-Palmolive India LimitedMumbai, Maharashtra
FDA-registered drug establishment in Mumbai, Maharashtra: analysis. Registration valid to 31 Dec 2026. Record as observed 27 Sep 2026.
- Inspections posted
- 4
- Last inspection
- Jul 2025 · VAI
- Warning letters to this FEI
- 0
- Import alerts at this address
- 0 of 2 under the name
- US border refusals, 2 years
- 4
This site, graded.
Every fact sourced.
- A grade from A to E on a registered ten-factor rubric, with the fact behind every factor
- Every posted FDA citation, sorted into failure categories and set against Indian drug inspections
- Warning-letter violations, numbered and labelled
- Import-alert history rebuilt from the archive, each listing checked against this address
- Border refusals by product, and the company's other sites, each graded
- A hash of every source read, so the PDF can be checked against the record
On 2022–26 inspections the rubric never saw, grade E sites were classified OAI 26.5% of the time and grade A sites 4.0%.
PDF and data by email, usually within minutes, as of the day you buy. Card payment through Razorpay.
By buying you agree to the Terms and the refund policy: sales are final once delivered, except non-delivery.
Consultant plan · US$799 a month · five dossiers a month and watchlist alerts. Ask about the plan
Inspections
4 FDA inspections of this FEI, by end date; 4 with a posted classification.
- 25 Jul 2025VAI · Voluntary Action IndicatedDrug Quality Assurance · 1 citation posted
- 3 May 2019VAI · Voluntary Action IndicatedDrug Quality Assurance · 2 citations posted
- 30 Jul 2014NAI · No Action IndicatedDrug Quality Assurance · no citations posted
- 3 Aug 2012VAI · Voluntary Action IndicatedDrug Quality Assurance · 2 citations posted
Warning letters and compliance actions
No FDA compliance action recorded against this FEI or letter to its name.
Import alerts in force
Import-alert pages list a firm name and an address, never an FEI. Each listing under this firm's name is shown with the address FDA published and whether it is this site's.
- 30 Dec 2019Import alert 66-41 · Published address is not this site SourceDetention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.Published address: 78 Epip Phase I , Plot No , Jhar Majri, Himachal Pradesh INDIA
- 12 Jan 2018Import alert 66-41 · Published address is not this site SourceDetention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.Published address: Sm - 02 Sanand , Plot , Gujrat, Punjab INDIA
Registration
- FEI
- 3004698222
- DUNS
- 650057904
- Registered as
- Colgate-Palmolive India Limited
- Registrant
- Coglate-Palmolive Company
- Address
- Colgate Research Centre, Main Street, Hiranandani Gardens, Powai, Mumbai, Maharashtra 400076, India (IND)
- Operations
- ANALYSIS
- Registration expires
- 31 Dec 2026
Sources: FDA drug establishment registrations, FDA Data Dashboard inspections and compliance actions, import-alert pages, warning letters, import refusals and the FDA reading room, as held in Counterfoil's point-in-time corpus. No matched action does not establish compliance, and FDA registration is not FDA approval. Sources and coverage.